Tag: volume-11-issue-1-2018

Gender Equality at Work

by Lisa Amatangelo, MD, RVT, FACPh and Julie Cardoso, RDCS, RVT, RPhS It is well known that there are gender differences that influence the medical profession, but are we aware of the gender inequities that continue to p...Continue Reading


Gender Equality at Work

by Lisa Amatangelo, MD, RVT, FACPh and Julie Cardoso, RDCS, RVT, RPhS It is well known that there are gender differences that influence the medical profession, but are we aware of the gender inequities that continue to p...Continue Reading


Optimizing Mid-Level Providers in a Busy Vein Practice

We both said “I do.” Three years ago we decided to add a certified nurse practitioner to our very busy practice. It was, and still is, one of the best decisions we have made. Mid-Level Practitioners Let&r...Continue Reading


Optimizing Mid-Level Providers in a Busy Vein Practice

We both said “I do.” Three years ago we decided to add a certified nurse practitioner to our very busy practice. It was, and still is, one of the best decisions we have made. Mid-Level Practitioners Let&r...Continue Reading


Practical Takeaways from the ATTRACT Trial: A Roundtable Discussion

Moderated by Steve Elias, MD, FACS, FACPh Participants: Suresh Vedantham, MD, FSIR (Principal Investigator), William (Bill) Marston, MD, Raghu Kolluri, MD and Darren Schneider, MD The landmark ATTRACT trial revealed t...Continue Reading


Practical Takeaways from the ATTRACT Trial: A Roundtable Discussion

Moderated by Steve Elias, MD, FACS, FACPh Participants: Suresh Vedantham, MD, FSIR (Principal Investigator), William (Bill) Marston, MD, Raghu Kolluri, MD and Darren Schneider, MD The landmark ATTRACT trial revealed t...Continue Reading


Reimbursements of New Technologies

One of the greatest concerns regarding coverage and reimbursement of novel medical interventions is that commercial payers throughout the U.S. operate largely with opaque business practices. They are part of decision-mak...Continue Reading


Reimbursements of New Technologies

One of the greatest concerns regarding coverage and reimbursement of novel medical interventions is that commercial payers throughout the U.S. operate largely with opaque business practices. They are part of decision-mak...Continue Reading


Single Session Venoplasty and Targeted Thrombolysis for Chronic Infrainguinal Venous Obstruction: A Novel Concept

by Raudel Garcia, MD, Paul Gagne, MD, Steve Elias, MD, Nicos Labropoulos, MD and Antonios P. Gasparis, MD Nearly 50 percent of patients with deep venous thrombosis (DVT) develop post-thrombotic syndrome (PTS).1,2 The s...Continue Reading


Single Session Venoplasty and Targeted Thrombolysis for Chronic Infrainguinal Venous Obstruction: A Novel Concept

by Raudel Garcia, MD, Paul Gagne, MD, Steve Elias, MD, Nicos Labropoulos, MD and Antonios P. Gasparis, MD Nearly 50 percent of patients with deep venous thrombosis (DVT) develop post-thrombotic syndrome (PTS).1,2 The s...Continue Reading